As detection and level of CGB protein is currently clinically utilized for pregnancy testing and as a clinical-grade biomarker of trophoblastic disease and germ cell tumors, we sought to explore the potential of CGB proteins as cancer biomarkers. This evidence concerns the gene CGB5 and cancer.